The Cystic Fibrosis Foundation awarded up to $3.5 million to Arrevus Inc. to test a potential treatment for pulmonary exacerbations in people with cystic fibrosis in a late phase clinical trial.
Site Search
Showing 11 - 17 of 17 results
News
|
Jan. 6, 2022
|
1 min read
This milestone was reached nearly two years ahead of the initiative’s five-year commitment. However, the Foundation aims to continue to support infection research at the same pace as it has in the past three years.
News
|
Jan. 28, 2022
|
7 min read
Dr. Steven Rowe will support mission to cure cystic fibrosis by leading the Foundation’s research strategy, focusing on genetic therapies
Press Release
|
Jan. 26, 2022
|
4 min read
Press Release
|
July 15, 2021
|
2 min read
Carbon Biosciences is the first company to publicly launch from the Foundation’s collaboration with Longwood Fund and the first to work alongside CF Foundation researchers at the Foundation’s therapeutics lab
Press Release
|
June 21, 2022
|
4 min read
Foundation welcomes new members to advance its mission
News
|
July 8, 2021
|
7 min read
A transformative leader for more than two decades, Marshall will transition to advisory role
News
|
March 6, 2024
|
3 min read